Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: findings from the opinion-based PREDICT-FD modified Delphi consensus initiative.
BMJ open, cilt.10, sa.10, 2020 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 10 Sayı: 10
- Basım Tarihi: 2020
- Doi Numarası: 10.1136/bmjopen-2019-035182
- Dergi Adı: BMJ open
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, Directory of Open Access Journals
- Anahtar Kelimeler: genetics, cardiomyopathy, chronic renal failure, stroke medicine, ENZYME REPLACEMENT THERAPY, UNCERTAIN DIAGNOSIS, AGALSIDASE BETA, FEMALE-PATIENTS, CHILDREN, BIOMARKER
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Gazi Üniversitesi Adresli: Evet
Özet
Objectives The PRoposing Early Disease Indicators for Clinical Tracking in Fabry Disease (PREDICT-FD) initiative aimed to reach consensus among a panel of global experts on early indicators of disease progression that may justify FD-specific treatment initiation.